Month: January 2021

Jan 27 2021

Uncategorized

New machine learning tool predicts schizophrenia

by Clinical Editor

No Comments

University of Alberta researchers have taken another step forward in developing an artificial intelligence tool to predict schizophrenia by analyzing brain scans.

Jan 27 2021

Uncategorized

AI Predicts Schizophrenia Symptoms in At-Risk Population

by Clinical Editor

No Comments

Researchers have taken another step forward in developing an artificial intelligence tool to predict schizophrenia by analyzing brain scans.

Jan 27 2021

Uncategorized

AI used to predict early symptoms of schizophrenia in relatives of patients

by Clinical Editor

No Comments

University of Alberta researchers have taken another step forward in developing an artificial intelligence tool to predict schizophrenia by analyzing brain scans.

Jan 27 2021

Uncategorized

New project to investigate a promising drug target for treatment of schizophrenia

by Clinical Editor

No Comments

A partnership between the University of Oxford, Earlham Institute (EI), and global pharmaceutical companies Biogen Inc and Boehringer Ingelheim will investigate a promising new drug target for the …

Jan 27 2021

Uncategorized

Machine learning tool used to predict early symptoms of schizophrenia in relatives of patients (image)

by Clinical Editor

No Comments

Sunil Kalmady Vasu (centre) led a recent study with fellow U of A researchers including Russ Greiner (left), Andrew Greenshaw (right) and Serdar Dursun (not pictured), showing that a machine...

Jan 26 2021

Uncategorized

Mad present, sane future: Doing right by the seriously mentally ill takes money and effort

by Clinical Editor

No Comments

The split-screen stories of two New Yorkers struggling with serious mental illness epitomize what is broken about the city’s patchwork mental health-care system.

Jan 26 2021

Uncategorized

New project to investigate a promising drug target for treatment of schizophrenia

by Clinical Editor

No Comments

A partnership between the University of Oxford, Earlham Institute (EI), and global pharmaceutical companies Biogen Inc and Boehringer Ingelheim will investigate a promising new drug target for the …

Jan 26 2021

Uncategorized

Family of mentally ill Ontario man who killed his mother day after seeing psychiatrist says doctors failed him

by Clinical Editor

No Comments

Family members of an Ontario man diagnosed with schizophrenia say his doctors didn’t do “their due diligence” when they failed to admit him to a hospital after he called a...

Jan 26 2021

Uncategorized

Investigating new treatment for schizophrenia as first Psychiatry Consortium funded project announce

by Clinical Editor

No Comments

A partnership between the University of Oxford, Earlham Institute (EI), and global pharmaceutical companies Biogen Inc and Boehringer Ingelheim will investigate a promising new drug target for the …

Jan 26 2021

Uncategorized

Increased risk of Parkinson’s disease in patients with schizophrenia

by Clinical Editor

No Comments

A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson’s disease later in life. The increased...